Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization

Published:2019-09-12 Issue:1 Volume:12 Page:92-100
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Sadeghi Amir¹,Behdani Mahdi¹,Muyldermans Serge²,Habibi‐Anbouhi Mahdi³,Kazemi‐Lomedasht Fatemeh¹^ORCID

Affiliation:

1. Biotechnology Research Center, Venom and Biotherapeutics Molecules Laboratory Pasteur Institute of Iran Tehran Iran

2. Laboratory of Cellular and Molecular Immunology Vrije Universiteit Brussel Brussels Belgium

3. National Cell Bank of Iran Pasteur Institute of Iran Tehran Iran

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2693

Reference44 articles.

1. Vascular endothelial growth factor (VEGF) and its receptors

2. The Biology of Vascular Endothelial Growth Factor

3. Mechanisms of angiogenesis

4. The biology of VEGF and its receptors

5. VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plug-and-play nucleic acid-mediated multimerization of biparatopic nanobodies for molecular imaging;Molecular Therapy - Nucleic Acids;2024-09

2. Single-Domain Antibodies—Novel Tools to Study and Treat Allergies;International Journal of Molecular Sciences;2024-07-11

3. A Nucleic Acid‐Based LYTAC Plus Platform to Simultaneously Mediate Disease‐Driven Protein Downregulation;Advanced Science;2024-01-22

4. Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management;Cancers;2024-01-15

5. Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy;Cell Death & Disease;2024-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3